CLINICAL_TRIALS
trial_result
· 2026-02-24
Clinical Trial Update: Study of Oxycyte in Severe Closed Head Injury [Phase 2]
Summary
A Phase 2 study of Oxycyte for traumatic brain injury has been terminated, and the results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tenax Therapeutics, Inc. | Conditions: Traumatic Brain Injury | Phase 2 | Status: TERMINATED | Results posted: 2026-02-24